You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
29 February 2024
BRAIN Biotech AG: Issuance of EUR 5 million convertible bond with exclusion of subscription rights
10 February 2023
BRAIN Biotech AG terminates contract for natural sweetener solution with Roquette Frères
10 January 2023
BRAIN Biotech AG: prioritizing development of therapeutic applications of the Akribion Genomics technology platform (genome-editing)
4 April 2022
BRAIN Biotech AG: Successful Genome Editing Activity in Mammalian Cells with BRAIN-Metagenome-Cas (BMC), BRAIN-Engineered-Cas (BEC)
1 February 2022
BRAIN Biotech AG: BRAIN Group expands its food enzyme business with the acquisition of a majority of Breatec B.V. and Comix
11 January 2022
BRAIN Biotech AG: BRAIN-Engineered-Cas (BEC) Considered a Patentable Technology